| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TPRA1 HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 ADGRL1 TSHR ADGRV1 GRM7 GALR2 GNRHR2 OR51Q1 LPAR6 TAS1R2 ADGRL2 GPR132 | 7.60e-07 | 884 | 105 | 18 | GO:0004930 |
| GeneOntologyMolecularFunction | transporter activity | HTR1B ATP7B ATP8A2 SLC44A2 SLC6A15 SLC44A4 SLC7A6 GRM7 ATP8B2 SVOPL SLC2A5 ITPR1 ITPR2 SFXN1 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 SFXN3 LRP2 NIPA1 | 7.61e-07 | 1289 | 105 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 4.98e-06 | 83 | 105 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TPRA1 HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 ADGRL1 TSHR ADGRV1 GRM7 GALR2 GNRHR2 SORT1 TGFBR2 OR51Q1 LPAR6 TAS1R2 PTCH2 ADGRL2 GPR132 | 6.34e-06 | 1353 | 105 | 21 | GO:0004888 |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 7.76e-06 | 8 | 105 | 3 | GO:0015220 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | HTR1B ATP7B SLC44A2 SLC6A15 SLC44A4 SLC7A6 GRM7 SVOPL SLC2A5 ITPR1 ITPR2 SFXN1 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 SFXN3 NIPA1 | 1.13e-05 | 1180 | 105 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | latrotoxin receptor activity | 2.74e-05 | 2 | 105 | 2 | GO:0016524 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.33e-05 | 35 | 105 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | HTR1B ATP7B SLC6A15 GRM7 ITPR1 ITPR2 SLC6A8 SLC9A3 KCNT2 SLC12A4 NIPA1 | 3.38e-05 | 465 | 105 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | serotonin binding | 3.89e-05 | 13 | 105 | 3 | GO:0051378 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.93e-05 | 14 | 105 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | HTR1B ATP7B SLC6A15 GRM7 ITPR1 ITPR2 SFXN1 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 SFXN3 NIPA1 | 6.96e-05 | 793 | 105 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | floppase activity | 7.53e-05 | 16 | 105 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 8.19e-05 | 3 | 105 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | flippase activity | 9.11e-05 | 17 | 105 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibitor activity | 1.63e-04 | 4 | 105 | 2 | GO:0010855 | |
| GeneOntologyMolecularFunction | galanin receptor activity | 1.63e-04 | 4 | 105 | 2 | GO:0004966 | |
| GeneOntologyMolecularFunction | amine binding | 1.75e-04 | 21 | 105 | 3 | GO:0043176 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | HTR1B ATP7B SLC6A15 GRM7 ITPR1 ITPR2 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 NIPA1 | 1.92e-04 | 664 | 105 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 2.02e-04 | 22 | 105 | 3 | GO:0004993 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.32e-04 | 105 | 105 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 2.71e-04 | 5 | 105 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | cyclase inhibitor activity | 2.71e-04 | 5 | 105 | 2 | GO:0010852 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 2.71e-04 | 5 | 105 | 2 | GO:0070915 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 4.21e-04 | 28 | 105 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | HTR1B ATP7B SLC6A15 GRM7 ITPR1 ITPR2 SLC6A8 SLC9A3 KCNT2 SLC12A4 NIPA1 | 4.61e-04 | 627 | 105 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 5.65e-04 | 7 | 105 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7B SLC44A2 SLC6A15 SLC44A4 SLC7A6 SLC6A8 SLC9A3 ATP8A1 SLC12A4 | 9.30e-04 | 477 | 105 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 9.63e-04 | 9 | 105 | 2 | GO:0015194 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 9.63e-04 | 9 | 105 | 2 | GO:0010854 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 9.63e-04 | 9 | 105 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 9.67e-04 | 296 | 105 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.30e-03 | 41 | 105 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | calcium ion binding | DSC1 SYT2 ADGRV1 GRM7 LRP1B ITPR1 ITPR2 SYT8 LRP2 SYT5 CDH18 | 1.95e-03 | 749 | 105 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | HTR1B ATP7B SLC6A15 GRM7 ITPR1 ITPR2 SLC6A8 SLC9A3 KCNT2 SLC12A4 NIPA1 | 2.14e-03 | 758 | 105 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.39e-03 | 14 | 105 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.45e-03 | 51 | 105 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.13e-03 | 16 | 105 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 3.13e-03 | 16 | 105 | 2 | GO:0045125 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 3.89e-03 | 60 | 105 | 3 | GO:0005544 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.97e-03 | 18 | 105 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 3.97e-03 | 18 | 105 | 2 | GO:0010851 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 4.06e-03 | 123 | 105 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.18e-03 | 288 | 105 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | clathrin binding | 4.46e-03 | 63 | 105 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.54e-03 | 293 | 105 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.77e-03 | 207 | 105 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.81e-03 | 129 | 105 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.86e-03 | 208 | 105 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.17e-03 | 211 | 105 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 5.17e-03 | 301 | 105 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.39e-03 | 21 | 105 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 5.91e-03 | 22 | 105 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | antiporter activity | 6.09e-03 | 138 | 105 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 6.23e-03 | 71 | 105 | 3 | GO:0015179 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 6.45e-03 | 23 | 105 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.45e-03 | 23 | 105 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 6.73e-03 | 73 | 105 | 3 | GO:0001786 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 6.99e-03 | 74 | 105 | 3 | GO:0005548 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 2.17e-06 | 73 | 107 | 6 | GO:0051339 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | TPRA1 HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 ADGRL1 TSHR ADGRV1 GRM7 GALR2 ADCY3 ITPR1 GNRHR2 SORT1 OR51Q1 LPAR6 TAS1R2 ADGRL2 GPR132 HTT | 2.31e-06 | 1395 | 107 | 22 | GO:0007186 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.41e-06 | 286 | 107 | 10 | GO:0007188 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.83e-06 | 21 | 107 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | negative regulation of lyase activity | 4.66e-06 | 22 | 107 | 4 | GO:0051350 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting serotonin receptor signaling pathway | 4.68e-06 | 7 | 107 | 3 | GO:0007198 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | HTR1A HTR1B ATP7B LMTK2 SLC6A15 GALR2 ATP8B2 AMIGO1 ITPR1 ITPR2 SFXN1 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 SFXN3 LRP2 CD63 NIPA1 HTT | 6.66e-06 | 1374 | 107 | 21 | GO:0006811 |
| GeneOntologyBiologicalProcess | amino acid transport | 8.10e-06 | 195 | 107 | 8 | GO:0006865 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 9.37e-06 | 26 | 107 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 9.37e-06 | 26 | 107 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 1.37e-05 | 59 | 107 | 5 | GO:0045761 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 1.61e-05 | 61 | 107 | 5 | GO:0007187 | |
| GeneOntologyBiologicalProcess | galanin-activated signaling pathway | 2.67e-05 | 2 | 107 | 2 | GO:0090663 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 2.95e-05 | 69 | 107 | 5 | GO:0031279 | |
| GeneOntologyBiologicalProcess | metal ion transport | ATP7B LMTK2 SLC6A15 GALR2 AMIGO1 ITPR1 ITPR2 SFXN1 SLC6A8 SLC9A3 KCNT2 SLC12A4 LRP2 CD63 NIPA1 HTT | 5.65e-05 | 1000 | 107 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP7B SLC6A15 GALR2 ATP8B2 AMIGO1 ITPR1 ITPR2 SFXN1 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 SFXN3 CD63 NIPA1 HTT | 5.88e-05 | 1115 | 107 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | serine import into mitochondrion | 7.97e-05 | 3 | 107 | 2 | GO:0140300 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP7B LMTK2 SLC6A15 GALR2 AMIGO1 ITPR1 ITPR2 SFXN1 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 LRP2 CD63 NIPA1 HTT | 9.26e-05 | 1157 | 107 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 1.05e-04 | 18 | 107 | 3 | GO:0007194 | |
| GeneOntologyBiologicalProcess | organic cation transport | 1.10e-04 | 145 | 107 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 1.24e-04 | 19 | 107 | 3 | GO:0031280 | |
| GeneOntologyBiologicalProcess | negative regulation of amino acid transport | 1.69e-04 | 21 | 107 | 3 | GO:0051956 | |
| GeneOntologyBiologicalProcess | feeding behavior | 2.01e-04 | 162 | 107 | 6 | GO:0007631 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 2.08e-04 | 163 | 107 | 6 | GO:1905039 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 2.23e-04 | 23 | 107 | 3 | GO:0098664 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 2.37e-04 | 167 | 107 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 2.64e-04 | 5 | 107 | 2 | GO:0006711 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 2.67e-04 | 60 | 107 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 2.86e-04 | 410 | 107 | 9 | GO:0046942 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 2.87e-04 | 25 | 107 | 3 | GO:0048791 | |
| GeneOntologyBiologicalProcess | organic acid transport | 2.96e-04 | 412 | 107 | 9 | GO:0015849 | |
| GeneOntologyBiologicalProcess | organic anion transport | HTR1A HTR1B SLC6A15 SLC44A4 SLC7A6 GRM7 SFXN1 SLC6A8 SFXN3 LRP2 | 3.48e-04 | 515 | 107 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | endocytosis | GAPVD1 HTR1B HEATR5A SYT2 LRP1B SORT1 TGFBR2 SLC9A3 ATP8A1 SYT8 LRP2 CD63 SYT5 | 3.52e-04 | 827 | 107 | 13 | GO:0006897 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP7B SLC6A15 GALR2 AMIGO1 ITPR1 ITPR2 SLC6A8 SLC9A3 ATP8A1 KCNT2 SLC12A4 CD63 NIPA1 HTT | 3.64e-04 | 942 | 107 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 3.95e-04 | 6 | 107 | 2 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 3.95e-04 | 6 | 107 | 2 | GO:0046226 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid translocation | 3.95e-04 | 6 | 107 | 2 | GO:0061092 | |
| GeneOntologyBiologicalProcess | negative regulation of gamma-aminobutyric acid secretion | 3.95e-04 | 6 | 107 | 2 | GO:0014053 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 3.95e-04 | 6 | 107 | 2 | GO:0051552 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid transport | 4.05e-04 | 28 | 107 | 3 | GO:0015812 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 4.07e-04 | 259 | 107 | 7 | GO:0006836 | |
| GeneOntologyBiologicalProcess | import into cell | GAPVD1 HTR1B HEATR5A SYT2 LRP1B SLC2A5 SORT1 TGFBR2 SLC9A3 ATP8A1 SLC12A4 SYT8 LRP2 CD63 SYT5 | 4.27e-04 | 1074 | 107 | 15 | GO:0098657 |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 4.90e-04 | 125 | 107 | 5 | GO:0016079 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid translocation | 5.50e-04 | 7 | 107 | 2 | GO:0061091 | |
| GeneOntologyBiologicalProcess | aminophospholipid translocation | 5.50e-04 | 7 | 107 | 2 | GO:0140331 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 5.65e-04 | 129 | 107 | 5 | GO:0042472 | |
| GeneOntologyBiologicalProcess | negative regulation of organic acid transport | 6.03e-04 | 32 | 107 | 3 | GO:0032891 | |
| GeneOntologyBiologicalProcess | neurotrophin TRK receptor signaling pathway | 7.23e-04 | 34 | 107 | 3 | GO:0048011 | |
| GeneOntologyBiologicalProcess | aminophospholipid transport | 9.37e-04 | 9 | 107 | 2 | GO:0015917 | |
| GeneOntologyBiologicalProcess | L-serine transport | 9.37e-04 | 9 | 107 | 2 | GO:0015825 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP7B SLC6A15 GALR2 AMIGO1 ITPR1 ITPR2 SLC6A8 SLC9A3 KCNT2 SLC12A4 CD63 NIPA1 HTT | 9.71e-04 | 922 | 107 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.05e-03 | 86 | 107 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | response to fructose | 1.17e-03 | 10 | 107 | 2 | GO:0009750 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.17e-03 | 10 | 107 | 2 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.17e-03 | 10 | 107 | 2 | GO:0009804 | |
| GeneOntologyBiologicalProcess | L-leucine transport | 1.17e-03 | 10 | 107 | 2 | GO:0015820 | |
| GeneOntologyBiologicalProcess | choline transport | 1.17e-03 | 10 | 107 | 2 | GO:0015871 | |
| GeneOntologyCellularComponent | secretory granule membrane | DSC1 SLC44A2 SYT2 SLC2A5 ITPR1 ITPR2 FAM170B CMTM6 ATP8A1 CD63 SYT5 | 1.10e-06 | 329 | 108 | 11 | GO:0030667 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ZFYVE27 DSC1 ATP8A2 SREBF1 SLC44A2 SYT2 TLR8 SLC2A5 ITPR1 ITPR2 SORT1 FAM170B CMTM6 SLC9A3 ATP8A1 SYT8 LRP2 CD63 SYT5 ATM HTT | 2.90e-06 | 1307 | 108 | 21 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ZFYVE27 DSC1 ATP8A2 SREBF1 SLC44A2 SYT2 TLR8 SLC2A5 ITPR1 ITPR2 SORT1 FAM170B CMTM6 SLC9A3 ATP8A1 SYT8 LRP2 CD63 SYT5 ATM HTT | 3.60e-06 | 1325 | 108 | 21 | GO:0012506 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 4.68e-05 | 14 | 108 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | transport vesicle | SREBF1 CACFD1 SYT2 ITPR1 SORT1 SSPN NRSN2 ATP8A1 SYT8 SYT5 ATM | 7.83e-05 | 519 | 108 | 11 | GO:0030133 |
| GeneOntologyCellularComponent | endosome | GAPVD1 ZFYVE27 ATP7B ATP8A2 LMTK2 CACFD1 WDFY4 PANK1 TLR8 SORT1 CMTM6 SLC9A3 LRP2 CD63 SYT5 NIPA1 HTT | 9.84e-05 | 1167 | 108 | 17 | GO:0005768 |
| GeneOntologyCellularComponent | recycling endosome | 1.56e-04 | 222 | 108 | 7 | GO:0055037 | |
| GeneOntologyCellularComponent | dense core granule | 2.01e-04 | 56 | 108 | 4 | GO:0031045 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RNF186 ZFYVE27 UGT1A10 SREBF1 UGT2A2 UGT1A9 CACFD1 ATP8B2 TLR8 ITPR1 ITPR2 SORT1 ERGIC1 ALG9 UGT2A1 PIGW HSD17B3 | 3.32e-04 | 1293 | 108 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RNF186 ZFYVE27 UGT1A10 SREBF1 UGT2A2 UGT1A9 CACFD1 ATP8B2 TLR8 ITPR1 ITPR2 SORT1 ERGIC1 ALG9 UGT2A1 PIGW HSD17B3 | 3.51e-04 | 1299 | 108 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | platelet dense granule membrane | 3.91e-04 | 6 | 108 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RNF186 ZFYVE27 UGT1A10 SREBF1 UGT2A2 UGT1A9 CACFD1 ATP8B2 TLR8 ITPR1 ITPR2 SORT1 ERGIC1 ALG9 UGT2A1 PIGW HSD17B3 | 4.48e-04 | 1327 | 108 | 17 | GO:0042175 |
| GeneOntologyCellularComponent | axon | HTR1A HTR1B ZFYVE27 LMTK2 ADGRL1 SYT2 GRM7 AMIGO1 ITPR2 SYT8 LRP2 SYT5 HTT | 6.85e-04 | 891 | 108 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | transport vesicle membrane | 8.26e-04 | 293 | 108 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | receptor complex | HTR1B TSHR ADGRV1 GRM7 LRP1B ITPR2 TGFBR2 TRBV19 TAS1R2 LRP2 | 8.59e-04 | 581 | 108 | 10 | GO:0043235 |
| GeneOntologyCellularComponent | chromaffin granule membrane | 9.30e-04 | 9 | 108 | 2 | GO:0042584 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 9.30e-04 | 9 | 108 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | specific granule membrane | 1.28e-03 | 91 | 108 | 4 | GO:0035579 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.41e-03 | 11 | 108 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | secretory vesicle | HTR1D DSC1 SLC44A2 CACFD1 SYT2 SLC2A5 ITPR1 ITPR2 FAM170B CMTM6 ATP8A1 SYT8 CD63 SYT5 ATM | 1.85e-03 | 1246 | 108 | 15 | GO:0099503 |
| GeneOntologyCellularComponent | presynapse | HTR1A HTR1B ADGRL1 CACFD1 SYT2 GRM7 ITPR1 ATP8A1 SYT8 SYT5 ATM HTT | 2.08e-03 | 886 | 108 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | secretory granule | HTR1D DSC1 SLC44A2 SYT2 SLC2A5 ITPR1 ITPR2 FAM170B CMTM6 ATP8A1 SYT8 CD63 SYT5 | 2.20e-03 | 1014 | 108 | 13 | GO:0030141 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.38e-03 | 179 | 108 | 5 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.38e-03 | 179 | 108 | 5 | GO:0030672 | |
| GeneOntologyCellularComponent | chromaffin granule | 2.66e-03 | 15 | 108 | 2 | GO:0042583 | |
| GeneOntologyCellularComponent | coated vesicle | 2.67e-03 | 360 | 108 | 7 | GO:0030135 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.73e-03 | 112 | 108 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | lysosomal membrane | 2.75e-03 | 462 | 108 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.75e-03 | 462 | 108 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.25e-03 | 583 | 108 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | early endosome | 3.51e-03 | 481 | 108 | 8 | GO:0005769 | |
| GeneOntologyCellularComponent | azurophil granule membrane | 3.53e-03 | 59 | 108 | 3 | GO:0035577 | |
| GeneOntologyCellularComponent | synaptic vesicle | 4.68e-03 | 300 | 108 | 6 | GO:0008021 | |
| GeneOntologyCellularComponent | vacuolar membrane | 4.81e-03 | 507 | 108 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | platelet dense granule | 5.21e-03 | 21 | 108 | 2 | GO:0042827 | |
| GeneOntologyCellularComponent | exocytic vesicle | 6.37e-03 | 320 | 108 | 6 | GO:0070382 | |
| Domain | 5HT_rcpt | 1.42e-05 | 9 | 105 | 3 | IPR002231 | |
| Domain | - | 3.00e-05 | 32 | 105 | 4 | 3.40.1110.10 | |
| Domain | - | 3.00e-05 | 32 | 105 | 4 | 2.70.150.10 | |
| Domain | MDFI | 3.13e-05 | 2 | 105 | 2 | PF15316 | |
| Domain | MDFI/MDFIC | 3.13e-05 | 2 | 105 | 2 | IPR026134 | |
| Domain | ATPase_P-typ_cyto_domN | 4.32e-05 | 35 | 105 | 4 | IPR023299 | |
| Domain | P_typ_ATPase | 4.84e-05 | 36 | 105 | 4 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 4.84e-05 | 36 | 105 | 4 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 4.84e-05 | 36 | 105 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 5.40e-05 | 37 | 105 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 5.40e-05 | 37 | 105 | 4 | PF00122 | |
| Domain | P_typ_ATPase_c | 6.01e-05 | 14 | 105 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 6.01e-05 | 14 | 105 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 6.01e-05 | 14 | 105 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 6.01e-05 | 14 | 105 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 6.01e-05 | 14 | 105 | 3 | PF16209 | |
| Domain | InsP3_rcpt-bd | 9.36e-05 | 3 | 105 | 2 | IPR000493 | |
| Domain | Galanin_rcpt | 9.36e-05 | 3 | 105 | 2 | IPR000405 | |
| Domain | Latrophilin | 9.36e-05 | 3 | 105 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 9.36e-05 | 3 | 105 | 2 | IPR003334 | |
| Domain | Synaptotagmin | 1.84e-04 | 20 | 105 | 3 | IPR001565 | |
| Domain | UDPGT | 2.13e-04 | 21 | 105 | 3 | PF00201 | |
| Domain | UDPGT | 2.13e-04 | 21 | 105 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 2.13e-04 | 21 | 105 | 3 | IPR002213 | |
| Domain | GPCR_2_latrophilin | 3.10e-04 | 5 | 105 | 2 | IPR003924 | |
| Domain | Mtc | 3.10e-04 | 5 | 105 | 2 | PF03820 | |
| Domain | Lectin_gal-bd_dom | 3.10e-04 | 5 | 105 | 2 | IPR000922 | |
| Domain | Gal_Lectin | 3.10e-04 | 5 | 105 | 2 | PF02140 | |
| Domain | Choline_transpo | 3.10e-04 | 5 | 105 | 2 | PF04515 | |
| Domain | SUEL_LECTIN | 3.10e-04 | 5 | 105 | 2 | PS50228 | |
| Domain | Mtc | 3.10e-04 | 5 | 105 | 2 | IPR004686 | |
| Domain | Choline_transptr-like | 3.10e-04 | 5 | 105 | 2 | IPR007603 | |
| Domain | 7tm_1 | HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 TSHR GALR2 GNRHR2 OR51Q1 LPAR6 GPR132 | 4.18e-04 | 677 | 105 | 12 | PF00001 |
| Domain | 7TM_GPCR_Srsx | 4.25e-04 | 112 | 105 | 5 | SM01381 | |
| Domain | - | 4.62e-04 | 64 | 105 | 4 | 3.40.50.1000 | |
| Domain | RIH_assoc | 4.63e-04 | 6 | 105 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 4.63e-04 | 6 | 105 | 2 | IPR013662 | |
| Domain | RIH_dom | 4.63e-04 | 6 | 105 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.63e-04 | 6 | 105 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.63e-04 | 6 | 105 | 2 | IPR015925 | |
| Domain | - | 4.63e-04 | 6 | 105 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.63e-04 | 6 | 105 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 4.63e-04 | 6 | 105 | 2 | PF08709 | |
| Domain | G_PROTEIN_RECEP_F1_1 | HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 TSHR GALR2 GNRHR2 OR51Q1 LPAR6 GPR132 | 4.65e-04 | 685 | 105 | 12 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 TSHR GALR2 GNRHR2 OR51Q1 LPAR6 GPR132 | 5.02e-04 | 691 | 105 | 12 | PS50262 |
| Domain | GPCR_Rhodpsn | HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 TSHR GALR2 GNRHR2 OR51Q1 LPAR6 GPR132 | 5.09e-04 | 692 | 105 | 12 | IPR000276 |
| Domain | GPS | 9.10e-04 | 34 | 105 | 3 | SM00303 | |
| Domain | GPS | 9.91e-04 | 35 | 105 | 3 | PF01825 | |
| Domain | HAD-like_dom | 1.03e-03 | 79 | 105 | 4 | IPR023214 | |
| Domain | GPS | 1.08e-03 | 36 | 105 | 3 | PS50221 | |
| Domain | Ptc/Disp | 1.10e-03 | 9 | 105 | 2 | IPR003392 | |
| Domain | Patched | 1.10e-03 | 9 | 105 | 2 | PF02460 | |
| Domain | GPS | 1.17e-03 | 37 | 105 | 3 | IPR000203 | |
| Domain | GPCR_Rhodpsn_7TM | HTR1A HTR1B HTR1D LPAR4 GALR3 GPR85 TSHR GALR2 OR51Q1 LPAR6 GPR132 | 1.37e-03 | 670 | 105 | 11 | IPR017452 |
| Domain | MIR | 1.37e-03 | 10 | 105 | 2 | PS50919 | |
| Domain | MIR | 1.37e-03 | 10 | 105 | 2 | PF02815 | |
| Domain | MIR | 1.37e-03 | 10 | 105 | 2 | SM00472 | |
| Domain | MIR_motif | 1.37e-03 | 10 | 105 | 2 | IPR016093 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.47e-03 | 40 | 105 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.47e-03 | 40 | 105 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.47e-03 | 40 | 105 | 3 | PS50227 | |
| Domain | GAIN_dom_N | 1.67e-03 | 11 | 105 | 2 | IPR032471 | |
| Domain | GAIN | 1.67e-03 | 11 | 105 | 2 | PF16489 | |
| Domain | NCD3G | 2.35e-03 | 13 | 105 | 2 | PF07562 | |
| Domain | OLF | 2.35e-03 | 13 | 105 | 2 | PS51132 | |
| Domain | GPCR_3_9-Cys_dom | 2.35e-03 | 13 | 105 | 2 | IPR011500 | |
| Domain | SSD | 2.35e-03 | 13 | 105 | 2 | IPR000731 | |
| Domain | SSD | 2.35e-03 | 13 | 105 | 2 | PS50156 | |
| Domain | Olfac-like_dom | 2.35e-03 | 13 | 105 | 2 | IPR003112 | |
| Domain | OLF | 2.35e-03 | 13 | 105 | 2 | SM00284 | |
| Domain | OLF | 2.35e-03 | 13 | 105 | 2 | PF02191 | |
| Domain | Ldl_recept_b | 2.73e-03 | 14 | 105 | 2 | PF00058 | |
| Domain | LDLRB | 2.73e-03 | 14 | 105 | 2 | PS51120 | |
| Domain | GPCR_3_CS | 2.73e-03 | 14 | 105 | 2 | IPR017979 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.79e-03 | 50 | 105 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.79e-03 | 50 | 105 | 3 | PF00002 | |
| Domain | ARM-type_fold | 3.04e-03 | 339 | 105 | 7 | IPR016024 | |
| Domain | LY | 3.13e-03 | 15 | 105 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.13e-03 | 15 | 105 | 2 | IPR000033 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.52e-03 | 18 | 105 | 2 | PS00754 | |
| Domain | GPCR_2_secretin-like | 4.68e-03 | 60 | 105 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.68e-03 | 60 | 105 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.91e-03 | 61 | 105 | 3 | PS50261 | |
| Domain | SNF | 5.03e-03 | 19 | 105 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.03e-03 | 19 | 105 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.03e-03 | 19 | 105 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 5.03e-03 | 19 | 105 | 2 | IPR000175 | |
| Pathway | WP_GPCRS_NONODORANT | HTR1A HTR1B HTR1D LPAR4 ADGRL1 TSHR GRM7 GALR2 LPAR6 ADGRL2 GPR132 | 2.55e-07 | 266 | 79 | 11 | MM15843 |
| Pathway | REACTOME_ASPIRIN_ADME | 4.98e-06 | 45 | 79 | 5 | MM15694 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HTR1A HTR1B HTR1D LPAR4 GALR3 TSHR GRM7 GALR2 ADCY3 ITPR1 ITPR2 LPAR6 TAS1R2 PTCH2 GPR132 | 6.80e-06 | 702 | 79 | 15 | M746 |
| Pathway | REACTOME_GLUCURONIDATION | 8.91e-06 | 24 | 79 | 4 | MM14599 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HTR1A HTR1B HTR1D LPAR4 GALR3 TSHR GRM7 GALR2 LPAR6 TAS1R2 PTCH2 GPR132 | 9.49e-06 | 463 | 79 | 12 | M507 |
| Pathway | REACTOME_GLUCURONIDATION | 1.06e-05 | 25 | 79 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.06e-05 | 25 | 79 | 4 | MM15820 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | HTR1A HTR1B HTR1D LPAR4 GALR3 TSHR GRM7 GALR2 ADCY3 ITPR1 ITPR2 LPAR6 TAS1R2 GPR132 | 1.23e-05 | 646 | 79 | 14 | MM14962 |
| Pathway | WP_GLUCURONIDATION | 1.24e-05 | 26 | 79 | 4 | M39404 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.05e-05 | 272 | 79 | 9 | M13380 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HTR1A HTR1B HTR1D LPAR4 GALR3 TSHR GRM7 GALR2 LPAR6 TAS1R2 GPR132 | 2.61e-05 | 430 | 79 | 11 | MM15160 |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 2.71e-05 | 11 | 79 | 3 | MM15008 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.95e-05 | 107 | 79 | 6 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.27e-05 | 109 | 79 | 6 | M18788 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 3.59e-05 | 12 | 79 | 3 | M6034 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 5.24e-05 | 37 | 79 | 4 | M42558 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 6.30e-05 | 314 | 79 | 9 | M600 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 9.23e-05 | 330 | 79 | 9 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 9.88e-05 | 333 | 79 | 9 | MM14963 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.01e-04 | 260 | 79 | 8 | M39397 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.05e-04 | 44 | 79 | 4 | M45014 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.51e-04 | 55 | 79 | 4 | M14933 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.51e-04 | 55 | 79 | 4 | M971 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.77e-04 | 23 | 79 | 3 | M47676 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.88e-04 | 57 | 79 | 4 | MM15643 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 3.07e-04 | 5 | 79 | 2 | M49000 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 3.15e-04 | 24 | 79 | 3 | M46445 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.56e-04 | 25 | 79 | 3 | M605 | |
| Pathway | REACTOME_DRUG_ADME | 3.61e-04 | 109 | 79 | 5 | M45012 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 4.58e-04 | 6 | 79 | 2 | M47960 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 5.02e-04 | 28 | 79 | 3 | M19580 | |
| Pathway | REACTOME_DRUG_ADME | 5.40e-04 | 119 | 79 | 5 | MM15692 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 6.09e-04 | 186 | 79 | 6 | MM15994 | |
| Pathway | WP_MONOAMINE_GPCRS | 6.80e-04 | 31 | 79 | 3 | MM15871 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP7B ATP8A2 SLC44A2 SLC6A15 SLC44A4 SLC7A6 ADCY3 ATP8B2 SLC9A3 ATP8A1 SLC12A4 NIPA1 | 7.66e-04 | 736 | 79 | 12 | M27287 |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 7.81e-04 | 74 | 79 | 4 | M48080 | |
| Pathway | WP_MONOAMINE_GPCRS | 8.19e-04 | 33 | 79 | 3 | M39585 | |
| Pathway | WP_PEPTIDE_GPCRS | 8.21e-04 | 75 | 79 | 4 | M39696 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR | 1.09e-03 | 9 | 79 | 2 | M47893 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.09e-03 | 9 | 79 | 2 | M47852 | |
| Pathway | WP_NRF2_PATHWAY | 1.16e-03 | 141 | 79 | 5 | M39454 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.16e-03 | 289 | 79 | 7 | MM15057 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.36e-03 | 10 | 79 | 2 | M47661 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP7B ATP8A2 SLC44A2 SLC6A15 SLC44A4 SLC7A6 ATP8B2 SLC9A3 ATP8A1 SLC12A4 NIPA1 | 1.39e-03 | 681 | 79 | 11 | MM14985 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.42e-03 | 219 | 79 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.45e-03 | 220 | 79 | 6 | M10320 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.55e-03 | 41 | 79 | 3 | M7399 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.55e-03 | 41 | 79 | 3 | M512 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 1.65e-03 | 11 | 79 | 2 | MM15049 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.65e-03 | 11 | 79 | 2 | M49033 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 1.65e-03 | 11 | 79 | 2 | M39422 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.65e-03 | 11 | 79 | 2 | M27466 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.66e-03 | 42 | 79 | 3 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.66e-03 | 42 | 79 | 3 | MM14971 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 1.97e-03 | 12 | 79 | 2 | M10960 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 1.97e-03 | 12 | 79 | 2 | MM15953 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.97e-03 | 12 | 79 | 2 | M39611 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.16e-03 | 238 | 79 | 6 | MM15076 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.32e-03 | 13 | 79 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.32e-03 | 13 | 79 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.32e-03 | 13 | 79 | 2 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.32e-03 | 13 | 79 | 2 | MM14553 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.70e-03 | 14 | 79 | 2 | M39328 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.71e-03 | 249 | 79 | 6 | M5988 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.91e-03 | 51 | 79 | 3 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.07e-03 | 52 | 79 | 3 | M14171 | |
| Pathway | PID_LPA4_PATHWAY | 3.11e-03 | 15 | 79 | 2 | M56 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 3.11e-03 | 15 | 79 | 2 | MM14762 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.15e-03 | 108 | 79 | 4 | M823 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.15e-03 | 108 | 79 | 4 | M17034 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.26e-03 | 109 | 79 | 4 | MM15074 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.42e-03 | 54 | 79 | 3 | M26911 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 3.54e-03 | 16 | 79 | 2 | MM15050 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.54e-03 | 16 | 79 | 2 | M26945 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 3.54e-03 | 16 | 79 | 2 | M6786 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 3.60e-03 | 55 | 79 | 3 | M47952 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.62e-03 | 183 | 79 | 5 | M39588 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.09e-08 | 101 | 108 | 7 | 23382219 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 16824687 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 20947505 | ||
| Pubmed | 1.53e-06 | 179 | 108 | 7 | 18577758 | ||
| Pubmed | Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. | 1.61e-06 | 8 | 108 | 3 | 11854302 | |
| Pubmed | 2.18e-06 | 67 | 108 | 5 | 20398908 | ||
| Pubmed | 3.20e-06 | 200 | 108 | 7 | 18240029 | ||
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 15919184 | ||
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 19032968 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 18855532 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 10734137 | ||
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 8.14e-06 | 13 | 108 | 3 | 11015572 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 8.14e-06 | 13 | 108 | 3 | 22085899 | |
| Pubmed | Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. | 9.55e-06 | 2 | 108 | 2 | 12555283 | |
| Pubmed | Effects of galanin receptor 2 and receptor 3 knockout in mouse models of acute seizures. | 9.55e-06 | 2 | 108 | 2 | 30298565 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17501853 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 1557407 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 1559993 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25540325 | ||
| Pubmed | Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. | 9.55e-06 | 2 | 108 | 2 | 9826725 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25170871 | ||
| Pubmed | Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. | 9.55e-06 | 2 | 108 | 2 | 1652050 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17417740 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15201137 | ||
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 9.55e-06 | 2 | 108 | 2 | 23582047 | |
| Pubmed | Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. | 9.55e-06 | 2 | 108 | 2 | 21333660 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12069904 | ||
| Pubmed | Genetic association of 5-HT1A and 5-HT1B gene polymorphisms with migraine in a Turkish population. | 9.55e-06 | 2 | 108 | 2 | 23375453 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25268648 | ||
| Pubmed | Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. | 9.55e-06 | 2 | 108 | 2 | 10788764 | |
| Pubmed | Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. | 9.55e-06 | 2 | 108 | 2 | 28017939 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9860934 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 1315531 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 9.55e-06 | 2 | 108 | 2 | 19120126 | |
| Pubmed | The HTR1A and HTR1B receptor genes influence stress-related information processing. | 9.55e-06 | 2 | 108 | 2 | 20638825 | |
| Pubmed | Specific association of megalin and the Na+/H+ exchanger isoform NHE3 in the proximal tubule. | 9.55e-06 | 2 | 108 | 2 | 10364184 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11080193 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24277524 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11164514 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22889491 | ||
| Pubmed | Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons. | 9.55e-06 | 2 | 108 | 2 | 10036246 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15211620 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26714589 | ||
| Pubmed | Acute serotonin 1B/1A receptor activation impairs behavioral flexibility in C57BL/6J mice. | 9.55e-06 | 2 | 108 | 2 | 35367298 | |
| Pubmed | [Association study of HTR1A and HTR1B with adolescent idiopathic scoliosis]. | 9.55e-06 | 2 | 108 | 2 | 20388441 | |
| Pubmed | SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. | 9.55e-06 | 2 | 108 | 2 | 19829169 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25547628 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12742250 | ||
| Pubmed | Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. | 9.55e-06 | 2 | 108 | 2 | 25016220 | |
| Pubmed | Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice. | 9.55e-06 | 2 | 108 | 2 | 37043976 | |
| Pubmed | Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice. | 9.55e-06 | 2 | 108 | 2 | 18155098 | |
| Pubmed | Involvement of Neuropeptide Galanin Receptors 2 and 3 in Learning, Memory and Anxiety in Aging Mice. | 9.55e-06 | 2 | 108 | 2 | 33915732 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18708078 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11504806 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11504805 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11504807 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 1565658 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29275155 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11483665 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22031623 | ||
| Pubmed | Elevated expression of galanin receptors in childhood neuroblastic tumors. | 9.55e-06 | 2 | 108 | 2 | 11867941 | |
| Pubmed | The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. | 9.55e-06 | 2 | 108 | 2 | 35039640 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28854359 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11376859 | ||
| Pubmed | Reappraisal of the serotonin 5-HT(1B) receptor gene in alcoholism: of mice and men. | 9.55e-06 | 2 | 108 | 2 | 11827742 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33436730 | ||
| Pubmed | 5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress. | 9.55e-06 | 2 | 108 | 2 | 24586946 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20089735 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15688089 | ||
| Pubmed | Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. | 9.55e-06 | 2 | 108 | 2 | 10359671 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32231393 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32360167 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 TM9SF3 SREBF1 SLC6A15 ST6GAL1 LRP1B ITPR1 ITPR2 SORT1 ERGIC1 SLC6A8 ALG9 ATM HTT | 2.16e-05 | 1201 | 108 | 14 | 35696571 |
| Pubmed | Association study of the serotoninergic system in migraine in the Spanish population. | 2.30e-05 | 18 | 108 | 3 | 19455600 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 ATP7B TM9SF3 SLC6A15 SLC7A6 ATP8B2 SORT1 TGFBR2 NRSN2 SLC12A4 INTS2 NIPA1 ATM | 2.61e-05 | 1061 | 108 | 13 | 33845483 |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19705758 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 10874040 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 10994649 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20395455 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17437169 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 25431134 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 15009141 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12110114 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 2.86e-05 | 3 | 108 | 2 | 20007669 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 18547250 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 36350267 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 32320395 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 11413485 | ||
| Pubmed | Expression of serotonin receptors in mouse oocytes and preimplantation embryos. | 2.86e-05 | 3 | 108 | 2 | 12678665 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.86e-05 | 3 | 108 | 2 | 1693919 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23955339 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.86e-05 | 3 | 108 | 2 | 24904548 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26845861 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21169892 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 18516987 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 31875875 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 31730796 | ||
| Pubmed | Sterol regulatory element-binding proteins are regulators of the NIS gene in thyroid cells. | 2.86e-05 | 3 | 108 | 2 | 23542164 | |
| Interaction | HTR1D interactions | 5.17e-07 | 4 | 103 | 3 | int:HTR1D | |
| Interaction | SYT1 interactions | 1.12e-06 | 105 | 103 | 7 | int:SYT1 | |
| Interaction | SLC17A2 interactions | 9.82e-06 | 56 | 103 | 5 | int:SLC17A2 | |
| Interaction | HTR1A interactions | 2.35e-05 | 33 | 103 | 4 | int:HTR1A | |
| Interaction | TTYH1 interactions | 2.35e-05 | 300 | 103 | 9 | int:TTYH1 | |
| Interaction | ATM interactions | 5.30e-05 | 333 | 103 | 9 | int:ATM | |
| Interaction | SLC22A4 interactions | 5.85e-05 | 192 | 103 | 7 | int:SLC22A4 | |
| Interaction | CNPY3 interactions | 6.66e-05 | 196 | 103 | 7 | int:CNPY3 | |
| Interaction | SYT5 interactions | 8.37e-05 | 17 | 103 | 3 | int:SYT5 | |
| Interaction | TSPAN15 interactions | 8.64e-05 | 276 | 103 | 8 | int:TSPAN15 | |
| Interaction | GPR17 interactions | 1.03e-04 | 283 | 103 | 8 | int:GPR17 | |
| GeneFamily | UDP glucuronosyltransferases | 1.35e-05 | 32 | 83 | 4 | 363 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 2.58e-05 | 13 | 83 | 3 | 170 | |
| GeneFamily | ATPase phospholipid transporting | 4.08e-05 | 15 | 83 | 3 | 1210 | |
| GeneFamily | Synaptotagmins | 6.06e-05 | 17 | 83 | 3 | 765 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 6.23e-05 | 3 | 83 | 2 | 297 | |
| GeneFamily | Galanin receptors | 6.23e-05 | 3 | 83 | 2 | 226 | |
| GeneFamily | Solute carriers | SLC25A34 SLC44A2 SLC6A15 SLC44A4 SLC7A6 SLC2A5 SLC6A8 SLC9A3 SLC12A4 | 8.17e-05 | 395 | 83 | 9 | 752 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 1.24e-04 | 4 | 83 | 2 | 918 | |
| GeneFamily | Sideroflexins | 2.06e-04 | 5 | 83 | 2 | 746 | |
| GeneFamily | Lysophosphatidic acid receptors | 3.09e-04 | 6 | 83 | 2 | 205 | |
| GeneFamily | CKLF like MARVEL transmembrane domain containing | 5.73e-04 | 8 | 83 | 2 | 978 | |
| GeneFamily | Low density lipoprotein receptors | 1.57e-03 | 13 | 83 | 2 | 634 | |
| Coexpression | MACAEVA_PBMC_RESPONSE_TO_IR | 4.92e-06 | 106 | 107 | 6 | M52 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | ZFYVE27 TM9SF3 SREBF1 SLC44A2 LMTK2 SLC7A6 ERGIC1 CMTM6 SLC12A4 ALG9 ADGRL2 HTT | 2.24e-05 | 681 | 107 | 12 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | ZFYVE27 TM9SF3 SREBF1 SLC44A2 LMTK2 SLC7A6 ERGIC1 CMTM6 SLC12A4 ALG9 ADGRL2 HTT | 3.06e-05 | 703 | 107 | 12 | MM1055 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | PAQR9 MDFIC HTR1A HTR1B ATP7B GALR3 SYT2 ADGRV1 TGFBR2 SLC9A3 SLC12A4 PTCH2 LRP2 CD63 PLD5 | 3.10e-05 | 1074 | 107 | 15 | M1941 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#1_top-relative-expression-ranked_200 | 2.07e-06 | 44 | 101 | 5 | gudmap_developingKidney_e15.5_early proxim tubul_200_k1 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#2 | HTR1A HTR1D LPAR4 CNFN ATP8A2 SYT2 ADGRV1 SLC44A4 TMEM132B PTCHD1 KCNT2 RBM47 | 1.28e-05 | 554 | 101 | 12 | Arv_SC_fibroblast_1000_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#1 | HTR1A HTR1D LPAR4 CNFN ATP8A2 SYT2 ADGRV1 SLC44A4 TMEM132B PTCHD1 KCNT2 RBM47 | 1.35e-05 | 557 | 101 | 12 | Arv_SC-HD_1000_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_200 | 6.18e-05 | 45 | 101 | 4 | gudmap_developingKidney_e15.5_S-shaped body_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_200 | 7.90e-05 | 149 | 101 | 6 | gudmap_developingKidney_e15.5_Proximal Tubules_200 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory|Liver / Manually curated celltypes from each tissue | 2.04e-07 | 171 | 108 | 7 | eb47f4a09a630ed14a0898377039ed50ef7cc292 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 160 | 108 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 160 | 108 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.81e-06 | 162 | 108 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 169 | 108 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.38e-06 | 175 | 108 | 6 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.38e-06 | 175 | 108 | 6 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 4.52e-06 | 176 | 108 | 6 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 177 | 108 | 6 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 177 | 108 | 6 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 185 | 108 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-06 | 187 | 108 | 6 | 23a42c172d5cc36cb8793c0bc2ce357c6c8e5d39 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-06 | 187 | 108 | 6 | 5ce7cf02990465b6f793205e4be07e8337b3570a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-06 | 187 | 108 | 6 | 17a37fc3a1d62fef3137e5ff26a84c0b8c80e124 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-06 | 187 | 108 | 6 | 1b0eb29394040555516677b9de75c15e769c4c53 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 187 | 108 | 6 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-06 | 187 | 108 | 6 | 11c773cf3dc1e725b7e4d8edd676c8a94a231d2a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-06 | 188 | 108 | 6 | c65fb9a3c910dd6166853f4f3a2f2c2411ccf03b | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.81e-06 | 189 | 108 | 6 | 389ccb68acb82893709f256315111470cf4beed3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.81e-06 | 189 | 108 | 6 | 58465b9407fbce91cca8f199950d6e0054c38fbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.81e-06 | 189 | 108 | 6 | 7ac78441a15a82218deaafd47accff2ea5c8de20 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-06 | 190 | 108 | 6 | d4f954e0748898df69e1710df558564db703dd61 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-05 | 139 | 108 | 5 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-05 | 139 | 108 | 5 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 144 | 108 | 5 | 121853910eeea1ea0642b3cc99f9200015480368 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.05e-05 | 148 | 108 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 148 | 108 | 5 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.15e-05 | 149 | 108 | 5 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.15e-05 | 149 | 108 | 5 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 149 | 108 | 5 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.30e-05 | 159 | 108 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-05 | 162 | 108 | 5 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-05 | 162 | 108 | 5 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 4.70e-05 | 162 | 108 | 5 | 44832055b11a789e320c802aadb345e065defc8f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 163 | 108 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 4.84e-05 | 163 | 108 | 5 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 163 | 108 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 4.98e-05 | 164 | 108 | 5 | 746833f74095c0f25ce76baf1069f1848c231933 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 5.59e-05 | 168 | 108 | 5 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 5.59e-05 | 168 | 108 | 5 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 5.59e-05 | 168 | 108 | 5 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.91e-05 | 170 | 108 | 5 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 170 | 108 | 5 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.91e-05 | 170 | 108 | 5 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.91e-05 | 170 | 108 | 5 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.42e-05 | 173 | 108 | 5 | 3aa1d28d4814798a772808ed29e1dbbdf92abd03 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 173 | 108 | 5 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | BL-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.42e-05 | 173 | 108 | 5 | 90700a876d997f7c0f7b3899dffcda7fdafee547 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.42e-05 | 173 | 108 | 5 | e8afef5ae68983eb8d6515b43952636a47e9d3d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.60e-05 | 174 | 108 | 5 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.78e-05 | 175 | 108 | 5 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 175 | 108 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 6.96e-05 | 176 | 108 | 5 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 7.15e-05 | 177 | 108 | 5 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 7.15e-05 | 177 | 108 | 5 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.35e-05 | 178 | 108 | 5 | be1d991c5a0a5be22f14f57d34ee1330f1a12963 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 178 | 108 | 5 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 178 | 108 | 5 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 178 | 108 | 5 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.54e-05 | 179 | 108 | 5 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.74e-05 | 180 | 108 | 5 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 108 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.95e-05 | 181 | 108 | 5 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.16e-05 | 182 | 108 | 5 | 94e70746e35a3062015d4b83ee545f4f84f47420 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.16e-05 | 182 | 108 | 5 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 92f54c267135cb5edbcacd26a0f29e62469bb7e5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.37e-05 | 183 | 108 | 5 | 23e55f88a802a9299d2773f9394970e86e8bbfaa | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial-AT2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.37e-05 | 183 | 108 | 5 | 0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 5c4f7d02ba3a3c4a22ac71302e7c9a47e205eef5 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 184 | 108 | 5 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 184 | 108 | 5 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 184 | 108 | 5 | 42cadfdb5d29a50bd7e901ddd14d42b39e8474f0 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 184 | 108 | 5 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | 8.59e-05 | 184 | 108 | 5 | 6f70d8f8ab8362d51f8a58735d42223e06566397 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 8.81e-05 | 185 | 108 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.04e-05 | 186 | 108 | 5 | e41f14aee8cfbf76b8d0d4695a6170e2cd92aec8 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.04e-05 | 186 | 108 | 5 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.04e-05 | 186 | 108 | 5 | b3633cd4e360c5b45060c50b4f606d483e03a89a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.04e-05 | 186 | 108 | 5 | 9dd31dc9af1704f35c74de726a6c27fa21e9a014 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 9.04e-05 | 186 | 108 | 5 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 9.27e-05 | 187 | 108 | 5 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-05 | 188 | 108 | 5 | 26c0a94951236a5d17a169920b0a8a9d0dd7d0ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-05 | 188 | 108 | 5 | af300574c4e95505f56bf716bcee1e4777944e8e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-05 | 188 | 108 | 5 | 5df5a0890e17d19f55770525345a656253696887 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-05 | 188 | 108 | 5 | e169e9bb85892e52880ee949d0f691d0ea0c8dc9 | |
| ToppCell | mild_COVID-19-CD8+_T_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 9.50e-05 | 188 | 108 | 5 | 60d27014e5f9e562efe2a602482ea1d07efd0331 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 188 | 108 | 5 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-05 | 188 | 108 | 5 | 9e923b0d79495ee1a3a097741a877f25d439eda3 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.50e-05 | 188 | 108 | 5 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-05 | 188 | 108 | 5 | 14dbc985abc2012c9f53deb243d465e4175f419f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.50e-05 | 188 | 108 | 5 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.50e-05 | 188 | 108 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 188 | 108 | 5 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-05 | 189 | 108 | 5 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B|Liver / Manually curated celltypes from each tissue | 9.74e-05 | 189 | 108 | 5 | 1ebff8185060d78f27f8d887e9adaa5f8faf2196 | |
| Drug | spirilene | 1.04e-07 | 3 | 108 | 3 | CID006436870 | |
| Drug | sumatriptan | 1.06e-07 | 80 | 108 | 7 | CID000005358 | |
| Drug | Zolmitriptan | 4.14e-07 | 4 | 108 | 3 | DB00315 | |
| Drug | Is 159 | 4.14e-07 | 4 | 108 | 3 | CID000196859 | |
| Drug | PD 158771 | 4.14e-07 | 4 | 108 | 3 | CID003075615 | |
| Drug | Naratriptan | 4.14e-07 | 4 | 108 | 3 | DB00952 | |
| Drug | LY206130 | 4.14e-07 | 4 | 108 | 3 | CID000124433 | |
| Drug | Sumatriptan | 4.14e-07 | 4 | 108 | 3 | DB00669 | |
| Drug | PD 118717 | 4.14e-07 | 4 | 108 | 3 | CID000128518 | |
| Drug | SKF 99101H | 4.14e-07 | 4 | 108 | 3 | CID000182576 | |
| Drug | sodium cholate | UGT1A10 GPR85 SREBF1 UGT1A9 LRP1B CMTM1 SLC12A4 UGT2A1 LRP2 MTRR HSD17B3 HTT | 5.53e-07 | 408 | 108 | 12 | CID000000303 |
| Drug | acotiamide | 8.45e-07 | 37 | 108 | 5 | CID005282338 | |
| Drug | Trelibet | 1.03e-06 | 5 | 108 | 3 | CID000065975 | |
| Drug | eptapirone | 1.03e-06 | 5 | 108 | 3 | CID000208928 | |
| Drug | CP-135,807 | 1.03e-06 | 5 | 108 | 3 | CID005487088 | |
| Drug | 4-amino-5-chloro-2-methoxybenzamide | 1.03e-06 | 5 | 108 | 3 | CID009834239 | |
| Drug | I 370 | 1.03e-06 | 5 | 108 | 3 | CID000089576 | |
| Drug | centbutindole | 1.03e-06 | 5 | 108 | 3 | CID000068663 | |
| Drug | CP-132,484 | 1.03e-06 | 5 | 108 | 3 | CID000132564 | |
| Drug | AC1LCKBJ | 1.03e-06 | 5 | 108 | 3 | CID000601768 | |
| Drug | San 21009 | 1.09e-06 | 17 | 108 | 4 | CID000152662 | |
| Drug | DP-5-CT | 1.39e-06 | 18 | 108 | 4 | CID000156314 | |
| Drug | 8-OH-DPAT | 1.43e-06 | 117 | 108 | 7 | CID000001220 | |
| Drug | Neurotensin (1-6) | 2.05e-06 | 6 | 108 | 3 | CID000137323 | |
| Drug | pyrrolo(1,2-a)quinoxaline | 2.05e-06 | 6 | 108 | 3 | CID000067476 | |
| Drug | (125i)gti | 2.05e-06 | 6 | 108 | 3 | CID000131670 | |
| Drug | R 28935 | 2.05e-06 | 6 | 108 | 3 | CID000093307 | |
| Drug | niaprazine | 2.05e-06 | 6 | 108 | 3 | CID000071919 | |
| Drug | 5-aminotryptamine | 2.05e-06 | 6 | 108 | 3 | CID003083677 | |
| Drug | NDO 008 | 2.05e-06 | 6 | 108 | 3 | CID000131001 | |
| Drug | clonidine | 2.19e-06 | 240 | 108 | 9 | CID000002803 | |
| Drug | GSK835726 | 3.28e-06 | 22 | 108 | 4 | CID005311268 | |
| Drug | alpha-methylserotonin | 3.28e-06 | 22 | 108 | 4 | CID000115292 | |
| Drug | GR127935 | 3.28e-06 | 22 | 108 | 4 | CID000107780 | |
| Drug | adafenoxate | 3.58e-06 | 7 | 108 | 3 | CID000064517 | |
| Drug | Eletriptan | 3.58e-06 | 7 | 108 | 3 | DB00216 | |
| Drug | BRL 34778 | 3.58e-06 | 7 | 108 | 3 | CID000135770 | |
| Drug | NAD-299 | 3.58e-06 | 7 | 108 | 3 | CID000451066 | |
| Drug | 2,2'-pyridylisatogen | 3.58e-06 | 7 | 108 | 3 | CID000124333 | |
| Drug | LY334370 | 3.58e-06 | 7 | 108 | 3 | CID005311258 | |
| Drug | [18f]fbway 1,3 N | 3.58e-06 | 7 | 108 | 3 | CID005352127 | |
| Drug | baclofen | 3.64e-06 | 191 | 108 | 8 | CID000002284 | |
| Drug | BP-554 | 5.71e-06 | 8 | 108 | 3 | CID000134117 | |
| Drug | AC1L5AAF | 5.71e-06 | 8 | 108 | 3 | CID000173615 | |
| Drug | SB 216641 | 5.71e-06 | 8 | 108 | 3 | CID003292447 | |
| Drug | cinitapride | 5.71e-06 | 8 | 108 | 3 | CID000068867 | |
| Drug | carmoxirole | 5.71e-06 | 8 | 108 | 3 | CID000057364 | |
| Drug | S 14489 | 5.71e-06 | 8 | 108 | 3 | CID000182595 | |
| Drug | 5-OHIP | 5.71e-06 | 8 | 108 | 3 | CID000182581 | |
| Drug | 5-fluoro-alpha-methyltryptamine | 5.71e-06 | 8 | 108 | 3 | CID000012834 | |
| Drug | mirtazapine | 5.75e-06 | 54 | 108 | 5 | CID000004205 | |
| Drug | 5-CT | 6.30e-06 | 55 | 108 | 5 | CID000001809 | |
| Drug | cyproheptadine | 6.49e-06 | 96 | 108 | 6 | CID000002913 | |
| Drug | norclozapine | 7.53e-06 | 57 | 108 | 5 | CID000002820 | |
| Drug | AC1NB8R3 | 8.12e-06 | 213 | 108 | 8 | CID004489307 | |
| Drug | melantonin | 8.54e-06 | 9 | 108 | 3 | CID000077899 | |
| Drug | CQ 32-084 | 8.54e-06 | 9 | 108 | 3 | CID000068847 | |
| Drug | AHPP | 8.54e-06 | 9 | 108 | 3 | CID000128891 | |
| Drug | S 15931 | 8.54e-06 | 9 | 108 | 3 | CID000182596 | |
| Drug | U91356A | 8.54e-06 | 9 | 108 | 3 | CID000132955 | |
| Drug | L-741,626 | 8.98e-06 | 28 | 108 | 4 | CID000133633 | |
| Drug | 5-OH-DPAT | 1.22e-05 | 10 | 108 | 3 | CID000172267 | |
| Drug | CM 29-712 | 1.22e-05 | 10 | 108 | 3 | CID000159842 | |
| Drug | Yohimbine | 1.22e-05 | 10 | 108 | 3 | DB01392 | |
| Drug | BIMT 17 BS | 1.22e-05 | 10 | 108 | 3 | CID006918248 | |
| Drug | 5-HTQ | 1.22e-05 | 10 | 108 | 3 | CID000656705 | |
| Drug | 2-(di-n-propylamino)tetralin | 1.22e-05 | 10 | 108 | 3 | CID000090285 | |
| Drug | seganserin | 1.22e-05 | 10 | 108 | 3 | CID000071767 | |
| Drug | S 14671 | 1.22e-05 | 10 | 108 | 3 | CID000131907 | |
| Drug | S 14297 | 1.22e-05 | 10 | 108 | 3 | CID000115007 | |
| Drug | LY344864 | 1.22e-05 | 10 | 108 | 3 | CID005311097 | |
| Drug | AC1L1CCX | 1.22e-05 | 10 | 108 | 3 | CID000001840 | |
| Drug | U-86170F | 1.22e-05 | 10 | 108 | 3 | CID000131559 | |
| Drug | SDZ 208-912 | 1.22e-05 | 10 | 108 | 3 | CID000058145 | |
| Drug | YM-09151-2 | 1.55e-05 | 32 | 108 | 4 | CID000004452 | |
| Drug | 3-nitro-4-hydroxyphenylacetic acid | 1.58e-05 | 112 | 108 | 6 | CID000447364 | |
| Drug | befloxatone | 1.67e-05 | 11 | 108 | 3 | CID000060824 | |
| Drug | alniditan | 1.67e-05 | 11 | 108 | 3 | CID000066004 | |
| Drug | AC1Q6F2A | 1.67e-05 | 11 | 108 | 3 | CID000060621 | |
| Drug | iodocyanopindolol | 1.76e-05 | 33 | 108 | 4 | CID000068618 | |
| Drug | haloperidol | 1.84e-05 | 394 | 108 | 10 | CID000003559 | |
| Drug | phenylbiguanide | 1.99e-05 | 34 | 108 | 4 | CID000004780 | |
| Drug | BRL15572 | 2.21e-05 | 12 | 108 | 3 | CID003654103 | |
| Drug | AMN082 | 2.21e-05 | 12 | 108 | 3 | CID001894360 | |
| Drug | xestospongin C | 2.21e-05 | 12 | 108 | 3 | ctd:C511704 | |
| Drug | sergolexole | 2.21e-05 | 12 | 108 | 3 | CID000060262 | |
| Drug | ocaperidone | 2.21e-05 | 12 | 108 | 3 | CID000071351 | |
| Drug | 6,7-DHT | 2.23e-05 | 2 | 108 | 2 | CID000039719 | |
| Drug | 8-methoxy-2'-chloro-PAT | 2.23e-05 | 2 | 108 | 2 | CID000125955 | |
| Drug | G-6-M | 2.23e-05 | 2 | 108 | 2 | CID000065891 | |
| Drug | 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole | 2.23e-05 | 2 | 108 | 2 | ctd:C025145 | |
| Drug | JMC-181 | 2.23e-05 | 2 | 108 | 2 | CID000134385 | |
| Drug | 8-Azabicyclo[3.2.1]oct-2-ene | 2.23e-05 | 2 | 108 | 2 | CID000138546 | |
| Drug | N,N-dipropyl-6,7-ADTN | 2.23e-05 | 2 | 108 | 2 | CID000125246 | |
| Drug | Frovatriptan | 2.23e-05 | 2 | 108 | 2 | DB00998 | |
| Drug | Almotriptan | 2.23e-05 | 2 | 108 | 2 | DB00918 | |
| Drug | 3-(4-piperidyl)-1H-indole | 2.23e-05 | 2 | 108 | 2 | CID000702235 | |
| Drug | tertatolol | 2.23e-05 | 2 | 108 | 2 | ctd:C005632 | |
| Drug | PD 128483 | 2.23e-05 | 2 | 108 | 2 | CID000130792 | |
| Drug | naratriptan | 2.23e-05 | 2 | 108 | 2 | ctd:C106783 | |
| Disease | congenital myasthenic syndrome 7 (implicated_via_orthology) | 1.70e-07 | 4 | 104 | 3 | DOID:0110659 (implicated_via_orthology) | |
| Disease | neuromuscular junction disease (implicated_via_orthology) | 4.23e-07 | 5 | 104 | 3 | DOID:439 (implicated_via_orthology) | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 2.35e-06 | 8 | 104 | 3 | DOID:14320 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | ATP7B SPATA18 LMTK2 LRP1B ITPR1 TGFBR2 RNASEL LRP2 FGF10 ATM HSD17B3 | 1.16e-05 | 616 | 104 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | ATP7B SPATA18 LMTK2 LRP1B ITPR1 TGFBR2 RNASEL LRP2 FGF10 ATM HSD17B3 | 1.16e-05 | 616 | 104 | 11 | C0376358 |
| Disease | Inherited neuropathies | 1.21e-05 | 40 | 104 | 4 | C0598589 | |
| Disease | Hypoxic Brain Damage | 1.23e-05 | 2 | 104 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 1.23e-05 | 2 | 104 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 1.23e-05 | 2 | 104 | 2 | C1527348 | |
| Disease | Anoxia of brain | 1.23e-05 | 2 | 104 | 2 | C0995195 | |
| Disease | Abnormality of the sense of smell, COVID-19 symptoms measurement, ageusia | 1.23e-05 | 2 | 104 | 2 | EFO_0600019, EFO_1001758, HP_0004408 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 2.30e-05 | 16 | 104 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Major Depressive Disorder | 2.54e-05 | 243 | 104 | 7 | C1269683 | |
| Disease | indole-3-carboxylate measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 3.68e-05 | 3 | 104 | 2 | EFO_0022216 | |
| Disease | hepcidin:ferritin ratio | 4.33e-05 | 55 | 104 | 4 | EFO_0007901 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.22e-04 | 5 | 104 | 2 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.22e-04 | 5 | 104 | 2 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.22e-04 | 5 | 104 | 2 | EFO_0801853 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.31e-04 | 28 | 104 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | xanthurenate measurement | 1.45e-04 | 29 | 104 | 3 | EFO_0010551 | |
| Disease | Child Development Disorders, Specific | 1.45e-04 | 29 | 104 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.45e-04 | 29 | 104 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 1.61e-04 | 30 | 104 | 3 | C0008073 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.77e-04 | 147 | 104 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.83e-04 | 6 | 104 | 2 | EFO_0800566 | |
| Disease | glucagon measurement | 2.20e-04 | 154 | 104 | 5 | EFO_0008463 | |
| Disease | X-21339 measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0800808 | |
| Disease | Unipolar Depression | 3.19e-04 | 259 | 104 | 6 | C0041696 | |
| Disease | Autistic Disorder | 3.33e-04 | 261 | 104 | 6 | C0004352 | |
| Disease | X-11793--oxidized bilirubin measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800766 | |
| Disease | X-11442 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.36e-04 | 9 | 104 | 2 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 5.44e-04 | 10 | 104 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | indoleacetate measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0021015 | |
| Disease | X-21448 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0800867 | |
| Disease | Depressive disorder | 5.70e-04 | 289 | 104 | 6 | C0011581 | |
| Disease | apolipoprotein B measurement | 5.71e-04 | 663 | 104 | 9 | EFO_0004615 | |
| Disease | pregnenetriol sulfate measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0010219 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.94e-04 | 12 | 104 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | p-cresol glucuronide measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0800079 | |
| Disease | biliverdin measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0021033 | |
| Disease | creatinine measurement, glomerular filtration rate | 7.95e-04 | 117 | 104 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | metabolite measurement | 8.38e-04 | 560 | 104 | 8 | EFO_0004725 | |
| Disease | Hypotension | 8.77e-04 | 53 | 104 | 3 | C0020649 | |
| Disease | pregnenetriol disulfate measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0800587 | |
| Disease | X-24588 measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0800898 | |
| Disease | retinol dehydrogenase 16 measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0802007 | |
| Disease | trimethylamine-N-oxide measurement | 1.09e-03 | 14 | 104 | 2 | EFO_0010541 | |
| Disease | urate measurement, spine bone mineral density | 1.14e-03 | 58 | 104 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.62e-03 | 17 | 104 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 1.62e-03 | 17 | 104 | 2 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0801382 | |
| Disease | migraine disorder, endometriosis | 2.21e-03 | 73 | 104 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | kidney disease (biomarker_via_orthology) | 2.47e-03 | 21 | 104 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | tissue factor measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0010623 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 2.48e-03 | 76 | 104 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | Parkinson's disease (is_implicated_in) | 2.48e-03 | 76 | 104 | 3 | DOID:14330 (is_implicated_in) | |
| Disease | Alcoholic Intoxication, Chronic | 2.64e-03 | 268 | 104 | 5 | C0001973 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.71e-03 | 22 | 104 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | complement factor H-like 1 protein measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0600092 | |
| Disease | Nonsyndromic Deafness | 2.97e-03 | 81 | 104 | 3 | C3711374 | |
| Disease | Mood Disorders | 3.00e-03 | 168 | 104 | 4 | C0525045 | |
| Disease | antiphospholipid syndrome | 3.23e-03 | 24 | 104 | 2 | EFO_0002689 | |
| Disease | Lynch syndrome (is_implicated_in) | 3.23e-03 | 24 | 104 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | snoring measurement | 3.30e-03 | 84 | 104 | 3 | EFO_0008341 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 3.41e-03 | 85 | 104 | 3 | EFO_0000708, EFO_0006953 | |
| Disease | Involutional paraphrenia | 3.50e-03 | 25 | 104 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 3.50e-03 | 25 | 104 | 2 | C1571984 | |
| Disease | Involutional Depression | 3.50e-03 | 25 | 104 | 2 | C0011574 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TCCTASILHLCVIAL | 131 | P28222 | |
| VVSCPAACLCASNIL | 31 | Q86WK6 | |
| LAKCLDVPFAICDCT | 306 | O76031 | |
| LIYLCIDICFPSNIC | 236 | Q6PL45 | |
| AFQTSITVLCIACPC | 971 | P35670 | |
| SLVCLAICISTFCFL | 871 | O94910 | |
| FLRCLLAFVSCICEL | 141 | Q9H6U8 | |
| MNAFILLLCEAPFCC | 66 | Q9UGQ2 | |
| CISGLCLAVLSHIFC | 5916 | Q8WXG9 | |
| VISLVCLAICIFTFC | 856 | O95490 | |
| FLDLALSCKAVICCR | 761 | Q9Y2Q0 | |
| FLDLALSCKAVICCR | 781 | Q9NTI2 | |
| LEFLETACACKAVIC | 791 | P98198 | |
| LLGVCCSVDNCRLFI | 141 | A0AV96 | |
| LVCETLQFLDCICGS | 1951 | Q14571 | |
| VLLLAFCACAVGLIA | 16 | P08962 | |
| CLDLACEFLCLLNPS | 4176 | Q9NZR2 | |
| ILACLFCEFLTLCNI | 171 | Q9P1T7 | |
| NLVCETLQFLDCICG | 2006 | Q14643 | |
| QILELENCLFTSICC | 956 | Q86W28 | |
| TLCLATLNCCFDPFI | 296 | Q99677 | |
| VDFCLLSDFIQEICC | 411 | Q8TC71 | |
| CACLLDLLLAFPSCQ | 421 | Q9UBK8 | |
| FIERCIQTFPTCCLL | 196 | Q6IB77 | |
| CTDLLLACFICPAVV | 306 | Q14C86 | |
| ICCCVLAVLPSLFLL | 151 | Q8NH59 | |
| AIISICCCLFILFLF | 26 | Q969X5 | |
| CCCLFILFLFLSELT | 31 | Q969X5 | |
| LLCNLREVQCLICCL | 986 | Q9H0H0 | |
| RALCAVCAPVSFLEC | 151 | Q6ZV70 | |
| CVCSLIILIVLIANC | 51 | Q8IWU2 | |
| TLCIAVSNCCFDPIV | 276 | P43657 | |
| AAVACTLLLALVACL | 6 | P98164 | |
| LLCLIFTCICGIQHL | 206 | Q6UVM3 | |
| ALCVAAGVLLAICLF | 121 | Q9GZP1 | |
| CVACCRVLPSLDALL | 206 | A6NMN3 | |
| VAFVLAVACTVACCK | 216 | Q6ZVX9 | |
| LVSAILLTTLAACCC | 636 | Q14392 | |
| IICTLSAIVCCIQIF | 186 | P81408 | |
| NLGVADLCFILCCVP | 66 | O43603 | |
| DLCFILCCVPFQATI | 71 | O43603 | |
| ILNLAVADLCFILCC | 61 | O60755 | |
| VADLCFILCCVPFQA | 66 | O60755 | |
| CPAVCCLTLALTTSI | 536 | Q13315 | |
| CEALCLLSTAFPVCI | 1026 | P42858 | |
| VSCLCVNLCSPYLLL | 1066 | Q86XA9 | |
| QVTCDLFIALDVLCC | 106 | P08908 | |
| DVLCCTSSILHLCAI | 116 | P08908 | |
| CCTASILHLCVIALD | 121 | P28221 | |
| FSCSCVVLLCTALVE | 636 | O60266 | |
| CLFCEFLTLCNIVLD | 171 | Q99750 | |
| FLTLCNIVLDCATCG | 176 | Q99750 | |
| LQVKVPLCACALCAT | 456 | O75426 | |
| TSCICPVLVCLCFVQ | 6 | Q13634 | |
| SVLLLCILFTCFCVT | 701 | Q08554 | |
| FPCCVLEVLLCALAA | 16 | Q14831 | |
| DLCCSDILRSAICFP | 61 | P60893 | |
| CTDIICCVFLLLAIV | 31 | Q8IWA5 | |
| SCTDVICCVLFLLFI | 31 | Q53GD3 | |
| CCCFLLLFLVSSVPV | 21 | O15520 | |
| LTGLLVCLACLAKCV | 11 | P37058 | |
| ALCLCLVLLAVLGCS | 226 | Q7RTP0 | |
| LCCLLTGCETFEEAL | 446 | Q8TE04 | |
| LFLCCISCDRFVAVV | 131 | Q9UNW8 | |
| AFCAICLKLLLCVQD | 61 | Q9NXI6 | |
| ILLCQHVFCEECLCL | 396 | Q96EX2 | |
| VAGLLLLTCCFCICK | 71 | Q8N9I0 | |
| VLVSGLLIFSCCFCL | 36 | O00445 | |
| LAAGVLLVSCLLCAA | 56 | Q8NBV8 | |
| KQPSICLCSLEDFLC | 661 | Q99523 | |
| ILTVICCLLAFCIGL | 496 | Q9H2J7 | |
| CCLLAFCIGLIFVQR | 501 | Q9H2J7 | |
| VGFCLVFATPLCCAL | 271 | Q9BWM7 | |
| LVGFCLVFATPLCCA | 271 | Q9H9B4 | |
| QKCIVIFALVCCFAI | 66 | Q8N7P1 | |
| CVFCLAILVFLINCV | 906 | Q14DG7 | |
| ACCLACVFTNPLEVV | 16 | Q6PIV7 | |
| IEAARIFCCNSCIAI | 396 | Q96NR3 | |
| LLGFSICLIACCVLT | 346 | P22732 | |
| ICLIACCVLTAALAL | 351 | P22732 | |
| LAVCILLVCTFLVCA | 966 | Q9Y6C5 | |
| FCCLFLLPLTAMAIC | 121 | Q96P88 | |
| LSAILAITFCGICCQ | 306 | P48764 | |
| FVCVTLCEQTLEACL | 431 | Q05823 | |
| CQAFCLLEAAASPIL | 591 | Q5VXU9 | |
| SCCVLVFLLFAVICV | 11 | P15907 | |
| LTCCLCDFGLSLRLD | 391 | P37173 | |
| LNLVCGLVCLLACFV | 201 | Q14714 | |
| SVALCCALCFVIDLS | 446 | P48029 | |
| IVLICCCCTLLTAIS | 156 | Q9UP95 | |
| ALCLFSSVCVVCAIS | 461 | Q8N434 | |
| EITQGLCFPAFCILC | 21 | Q7Z7B1 | |
| CTLVFLCLSCNPLAS | 491 | P36956 | |
| CLTAVIVCCIDAFVV | 116 | Q8IZ96 | |
| LAFICEEVVSQCTLC | 51 | Q9NX76 | |
| AALTFCLPCALCQMA | 91 | Q9BYD5 | |
| LTCIFLLISGSCELC | 11 | Q9NR97 | |
| RSLVLVCVLAALCFA | 121 | Q6YI46 | |
| VCVLAALCFASLALV | 126 | Q6YI46 | |
| SVLLCFDIIEGLCCV | 246 | Q86W33 | |
| NLICETDRSLLCFLC | 101 | I1YAP6 | |
| LICCLLTCLLVDCFS | 71 | Q6XCG6 | |
| PLCVCLLLTCGFAEA | 11 | Q9HAW8 | |
| FVLSIIITLCCVFNC | 66 | Q8NEW7 | |
| VLRCVCFFCSKLLVD | 106 | P24928 | |
| LLIATTCLREHSCCF | 221 | Q6ZS81 | |
| PLCVCLLLTCGFAEA | 11 | O60656 | |
| LFCVKDLEILCTQCS | 106 | Q495X7 | |
| LFPLCFTICISCIAV | 636 | Q8TE23 | |
| VAVCCICFFVILPLN | 396 | Q9HD45 | |
| TLGLCLCAVLCCFLV | 166 | O14836 | |
| CRLLAAACICLLTFV | 166 | Q92536 | |
| LEAFLSRLCCTCEAA | 156 | Q5T4F4 | |
| CLACLLKLICQFAVD | 1521 | Q70CQ2 | |
| LVCVTTAIFLVIQCC | 496 | P0DTE4 | |
| LCCVVLCLLGANTVD | 6 | A0A075B6N1 | |
| VCVTTAIFLVIQCCL | 506 | P0DTE5 | |
| VLTLNIVAFVIVCCC | 586 | P16473 |